drugset / Trial / NCT06670898

A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects

NCT06670898 ↗

Phase 1 Completed 8 enrolled Nippon Shinyaku Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study was to determine the absorption, metabolism, and excretion of radioactivity and to characterize and determine, where possible, the metabolites present in plasma, urine, and faeces in healthy male subjects following a single oral administration of \[14C\]-NS-580.

Timeline

Start
2023-11-08
Primary completion
2024-01-18
Completion
2024-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject NS-580 Unknown — Oral

Indications

No indication recorded.